{
  "id": "3f0b175312ce8303",
  "title": "Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million . Is the Stock a Buy ? ",
  "description": "20260125T003000Z",
  "content": "",
  "source": "fool.com",
  "source_url": "https://www.fool.com/coverage/filings/2026/01/24/palisades-investment-initiated-a-position-in-travere-therapeutics-worth-over-usd5-million-is-the-stock-a-buy/?source=iedfolrf0000001",
  "published_at": "20260125T003000Z",
  "fetched_at": "2026-01-26T00:26:00.962189+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.fool.com/coverage/filings/2026/01/24/palisades-investment-initiated-a-position-in-travere-therapeutics-worth-over-usd5-million-is-the-stock-a-buy/?source=iedfolrf0000001",
    "url_mobile": "",
    "title": "Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million . Is the Stock a Buy ? ",
    "seendate": "20260125T003000Z",
    "socialimage": "https://cdn.content.foolcdn.com/images/1umn9qeh/production/37a7f80f063688ddbd3b84d74a534e9e7a0367b6-1401x1251.png",
    "domain": "fool.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}